T
,Contents
Chapter 01: The Nursing Process and Drug Therapy .................................................................................... 4
Chapter 02: Pharmacologic Principles .......................................................................................................... 8
Chapter 03: Lifespan Considerations .......................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ..................................................................... 26
Chapter 06: Patient Education and Drug Therapy ...................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics .................................................................................. 38
Chapter 09: Photo Atlas of Drug Administration ........................................................................................ 41
Chapter 10: Analgesic Drugs ....................................................................................................................... 50
Chapter 11: General and Local Anesthetics ................................................................................................ 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs ......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson Drugs ................................................................................................................ 76
Chapter 16: Psychotherapeutic Drugs ........................................................................................................ 81
Chapter 17: Substance Use Disorder .......................................................................................................... 88
Chapter 18: Adrenergic Drugs ..................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs ...................................................................................................... 98
Chapter 20: Cholinergic Drugs .................................................................................................................. 103
Chapter 21: Cholinergic-Blocking Drugs.................................................................................................... 108
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ............................................................................................................... 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs .................................................................................................. 137
Chapter 27: Antilipemic Drugs .................................................................................................................. 143
Chapter 28: Diuretic Drugs ........................................................................................................................ 148
Chapter 29: Fluids and Electrolytes .......................................................................................................... 154
Chapter 30: Pituitary Drugs ....................................................................................................................... 160
,Chapter 31: Thyroid and Antithyroid Drugs .............................................................................................. 163
Chapter 32: Antidiabetic Drugs ................................................................................................................. 168
Chapter 33: Adrenal Drugs ........................................................................................................................ 177
Chapter 34: Women’s Health Drugs ......................................................................................................... 181
Chapter 35: Men’s Health Drugs ............................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ......................................... 193
Chapter 37: Respiratory Drugs .................................................................................................................. 198
Chapter 38: Antibiotics Part 1 ................................................................................................................... 204
Chapter 39: Antibiotics Part 2 ................................................................................................................... 211
Chapter 40: Antiviral Drugs ....................................................................................................................... 216
Chapter 41: Antitubercular Drugs ............................................................................................................. 221
Chapter 42: Antifungal Drugs .................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ........................................................... 231
Chapter 44: Anti-inflammatory and Antigout Drugs ................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ...................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ......... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ...................................................... 253
Chapter 48: Immunosuppressant Drugs ................................................................................................... 258
Chapter 49: Immunizing Drugs.................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs .......................................................................................................... 268
Chapter 51: Bowel Disorder Drugs ............................................................................................................ 274
Chapter 52: Antiemetic and Antinausea Drugs......................................................................................... 281
Chapter 53: Vitamins and Minerals........................................................................................................... 286
Chapter 54: Anemia Drugs ........................................................................................................................ 292
Chapter 55: Nutritional Supplements ....................................................................................................... 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Chapter 57: Ophthalmic Drugs.................................................................................................................. 310
Chapter 58: Otic Drugs .............................................................................................................................. 315
, Chapter 01: The Nursing Process and Drug Therapy 4
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The wnurse wis wwriting wa wnursing wdiagnosis wfor wa wplan wof wcare wfor wa wpatient wwho
whas wbeen wnewlywdiagnosed wwith wtype w2 wdiabetes. wWhich wstatement wreflects wthe
wcorrect wformat wfor wa wnursing wdiagnosis?
a. Anxiety
b. Anxiety wrelated wto wnew wdrug wtherapy
c. Anxiety wrelated wto wanxious wfeelings wabout wdrug wtherapy, was wevidenced wby
wstatementswsuch was w―I‘m wupset wabout whaving wto wtest wmy wblood wsugars.‖
d. Anxiety wrelated wto wnew wdrug wtherapy, was wevidenced wby wstatements
wsuch was w―I‘m wupset wabout whaving wto wtest wmy wblood wsugars.‖
ANS: w D
Formulation wof wnursing wdiagnoses wis wusually wa wthree-step wprocess. w―Anxiety‖ wis wmissing
wthe
―related wto‖ wand w―as wevidenced wby‖ wportions wof wdefining wcharacteristics. w―Anxiety
wrelated wto wnew wdrug wtherapy‖ wis wmissing wthe w―as wevidenced wby‖ wportion wof wdefining
wcharacteristics. wThe wstatementwbeginning w―Anxiety wrelated wto wanxious wfeelings‖ wis
wincorrect wbecause wthe w―related wto‖ wsection wis wsimply wa wrestatement wof wthe wproblem
w―anxiety,‖ wnot wa wseparate wfactor wrelated wto wthe wresponse.
DIF: COGNITIVE wLEVEL: wUnderstanding
w(Comprehension)wTOP: w NURSING wPROCESS: wNursing
wDiagnosis
MSC: w NCLEX: wSafe wand wEffective wCare wEnvironment: wManagement wof wCare
2. The wpatient wis wto wreceive woral wguaifenesin w(Mucinex) wtwice wa wday. wToday, wthe wnurse
wwas wbusy wandwgave wthe wmedication w2 whours wafter wthe wscheduled wdose wwas wdue.
wWhat wtype wof wproblem wdoes wthis wrepresent?
a. ―Right wtime‖
b. ―Right wdose‖
c. ―Right wroute‖
d. ―Right wmedication‖
ANS: w A
―Right wtime‖ wis wcorrect wbecause wthe wmedication wwas wgiven wmore wthan w30 wminutes
wafter wthe wscheduled wdose wwas wdue. w―Dose‖ wis wincorrect wbecause wthe wdose wis wnot
wrelated wto wthe wtime wthe wmedication wadministration wis wscheduled. w―Route‖ wis wincorrect
wbecause wthe wroute wis wnot waffected.
―Medication‖ wis wincorrect wbecause wthe wmedication wordered wwill wnot wchange.
DIF: COGNITIVE wLEVEL: wApplying
w(Application)wTOP: w NURSING wPROCESS:
wImplementation
MSC: w NCLEX: wSafe wand wEffective wCare wEnvironment: wSafety wand wInfection wControl
3. The wnurse whas wbeen wmonitoring wthe wpatient‘s wprogress won wa wnew wdrug wregimen wsince
wthe wfirst wdosewand wdocumenting wthe wpatient‘s wtherapeutic wresponse wto wthe wmedication.
wWhich wphase wof wthe wnursing wprocess wdo wthese wactions willustrate?
a. Nursing wdiagnosis
,Contents
Chapter 01: The Nursing Process and Drug Therapy .................................................................................... 4
Chapter 02: Pharmacologic Principles .......................................................................................................... 8
Chapter 03: Lifespan Considerations .......................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ..................................................................... 26
Chapter 06: Patient Education and Drug Therapy ...................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics .................................................................................. 38
Chapter 09: Photo Atlas of Drug Administration ........................................................................................ 41
Chapter 10: Analgesic Drugs ....................................................................................................................... 50
Chapter 11: General and Local Anesthetics ................................................................................................ 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants ................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs ......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson Drugs ................................................................................................................ 76
Chapter 16: Psychotherapeutic Drugs ........................................................................................................ 81
Chapter 17: Substance Use Disorder .......................................................................................................... 88
Chapter 18: Adrenergic Drugs ..................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs ...................................................................................................... 98
Chapter 20: Cholinergic Drugs .................................................................................................................. 103
Chapter 21: Cholinergic-Blocking Drugs.................................................................................................... 108
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ............................................................................................................... 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs .................................................................................................. 137
Chapter 27: Antilipemic Drugs .................................................................................................................. 143
Chapter 28: Diuretic Drugs ........................................................................................................................ 148
Chapter 29: Fluids and Electrolytes .......................................................................................................... 154
Chapter 30: Pituitary Drugs ....................................................................................................................... 160
,Chapter 31: Thyroid and Antithyroid Drugs .............................................................................................. 163
Chapter 32: Antidiabetic Drugs ................................................................................................................. 168
Chapter 33: Adrenal Drugs ........................................................................................................................ 177
Chapter 34: Women’s Health Drugs ......................................................................................................... 181
Chapter 35: Men’s Health Drugs ............................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ......................................... 193
Chapter 37: Respiratory Drugs .................................................................................................................. 198
Chapter 38: Antibiotics Part 1 ................................................................................................................... 204
Chapter 39: Antibiotics Part 2 ................................................................................................................... 211
Chapter 40: Antiviral Drugs ....................................................................................................................... 216
Chapter 41: Antitubercular Drugs ............................................................................................................. 221
Chapter 42: Antifungal Drugs .................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ........................................................... 231
Chapter 44: Anti-inflammatory and Antigout Drugs ................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ...................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ......... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ...................................................... 253
Chapter 48: Immunosuppressant Drugs ................................................................................................... 258
Chapter 49: Immunizing Drugs.................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs .......................................................................................................... 268
Chapter 51: Bowel Disorder Drugs ............................................................................................................ 274
Chapter 52: Antiemetic and Antinausea Drugs......................................................................................... 281
Chapter 53: Vitamins and Minerals........................................................................................................... 286
Chapter 54: Anemia Drugs ........................................................................................................................ 292
Chapter 55: Nutritional Supplements ....................................................................................................... 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Chapter 57: Ophthalmic Drugs.................................................................................................................. 310
Chapter 58: Otic Drugs .............................................................................................................................. 315
, Chapter 01: The Nursing Process and Drug Therapy 4
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. The wnurse wis wwriting wa wnursing wdiagnosis wfor wa wplan wof wcare wfor wa wpatient wwho
whas wbeen wnewlywdiagnosed wwith wtype w2 wdiabetes. wWhich wstatement wreflects wthe
wcorrect wformat wfor wa wnursing wdiagnosis?
a. Anxiety
b. Anxiety wrelated wto wnew wdrug wtherapy
c. Anxiety wrelated wto wanxious wfeelings wabout wdrug wtherapy, was wevidenced wby
wstatementswsuch was w―I‘m wupset wabout whaving wto wtest wmy wblood wsugars.‖
d. Anxiety wrelated wto wnew wdrug wtherapy, was wevidenced wby wstatements
wsuch was w―I‘m wupset wabout whaving wto wtest wmy wblood wsugars.‖
ANS: w D
Formulation wof wnursing wdiagnoses wis wusually wa wthree-step wprocess. w―Anxiety‖ wis wmissing
wthe
―related wto‖ wand w―as wevidenced wby‖ wportions wof wdefining wcharacteristics. w―Anxiety
wrelated wto wnew wdrug wtherapy‖ wis wmissing wthe w―as wevidenced wby‖ wportion wof wdefining
wcharacteristics. wThe wstatementwbeginning w―Anxiety wrelated wto wanxious wfeelings‖ wis
wincorrect wbecause wthe w―related wto‖ wsection wis wsimply wa wrestatement wof wthe wproblem
w―anxiety,‖ wnot wa wseparate wfactor wrelated wto wthe wresponse.
DIF: COGNITIVE wLEVEL: wUnderstanding
w(Comprehension)wTOP: w NURSING wPROCESS: wNursing
wDiagnosis
MSC: w NCLEX: wSafe wand wEffective wCare wEnvironment: wManagement wof wCare
2. The wpatient wis wto wreceive woral wguaifenesin w(Mucinex) wtwice wa wday. wToday, wthe wnurse
wwas wbusy wandwgave wthe wmedication w2 whours wafter wthe wscheduled wdose wwas wdue.
wWhat wtype wof wproblem wdoes wthis wrepresent?
a. ―Right wtime‖
b. ―Right wdose‖
c. ―Right wroute‖
d. ―Right wmedication‖
ANS: w A
―Right wtime‖ wis wcorrect wbecause wthe wmedication wwas wgiven wmore wthan w30 wminutes
wafter wthe wscheduled wdose wwas wdue. w―Dose‖ wis wincorrect wbecause wthe wdose wis wnot
wrelated wto wthe wtime wthe wmedication wadministration wis wscheduled. w―Route‖ wis wincorrect
wbecause wthe wroute wis wnot waffected.
―Medication‖ wis wincorrect wbecause wthe wmedication wordered wwill wnot wchange.
DIF: COGNITIVE wLEVEL: wApplying
w(Application)wTOP: w NURSING wPROCESS:
wImplementation
MSC: w NCLEX: wSafe wand wEffective wCare wEnvironment: wSafety wand wInfection wControl
3. The wnurse whas wbeen wmonitoring wthe wpatient‘s wprogress won wa wnew wdrug wregimen wsince
wthe wfirst wdosewand wdocumenting wthe wpatient‘s wtherapeutic wresponse wto wthe wmedication.
wWhich wphase wof wthe wnursing wprocess wdo wthese wactions willustrate?
a. Nursing wdiagnosis
